- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有69家主力机构披露2025-06-30报告期持股数据，持仓量总计9803.77万股，占流通A股17.42%
- 波段诊断：
-
技术面诊股
诊断结果：4.2技术面打败了34%的股票
技术面评分前10的股票
近期的平均成本为15.12元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为15.12元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.12","date":1765786362,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.12.16","stock":"-1.89","trade":null,"ind":"-1.51"},{"date":"2025.12.15","stock":"0.33","trade":null,"ind":"-1.10"},{"date":"2025.12.12","stock":"-0.20","trade":null,"ind":"0.84"},{"date":"2025.12.11","stock":"-1.23","trade":null,"ind":"-1.27"},{"date":"2025.12.10","stock":"0.26","trade":null,"ind":"0.29"},{"date":"2025.12.09","stock":"-1.47","trade":null,"ind":"-0.39"},{"date":"2025.12.08","stock":"0.45","trade":null,"ind":"1.39"},{"date":"2025.12.05","stock":"1.49","trade":null,"ind":"1.08"},{"date":"2025.12.04","stock":"-1.35","trade":null,"ind":"0.40"},{"date":"2025.12.03","stock":"0.13","trade":null,"ind":"-0.78"},{"date":"2025.12.02","stock":"-1.52","trade":null,"ind":"-0.68"},{"date":"2025.12.01","stock":"-0.63","trade":null,"ind":"1.25"},{"date":"2025.11.28","stock":"0.25","trade":null,"ind":"0.85"},{"date":"2025.11.27","stock":"-1.55","trade":null,"ind":"-0.25"},{"date":"2025.11.26","stock":"2.35","trade":null,"ind":"1.02"},{"date":"2025.11.25","stock":"0.38","trade":null,"ind":"1.53"},{"date":"2025.11.24","stock":"-0.19","trade":null,"ind":"0.37"},{"date":"2025.11.21","stock":"-4.14","trade":null,"ind":"-3.41"},{"date":"2025.11.20","stock":"-2.84","trade":null,"ind":"-0.76"},{"date":"2025.11.19","stock":"-4.14","trade":null,"ind":"-0.00"},{"date":"2025.11.18","stock":"-1.34","trade":null,"ind":"-0.92"}]
东富龙,深证成指,医疗器械指数
压力支撑
该股压力位为15.17元，支撑位为14.93元。
[{"text":"\u538b\u529b\u4f4d","value":"15.17","date":1765814400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.93","date":1765814400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了42%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月16日 20:30
| 机构今日流向(万元) | -303.60 | 机构5日流向(万元) | -1916.26 |
| 机构10日流向(万元) | -3819.59 | 机构20日流向(万元) | -9955.06 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少8.91万股，其中基金净减仓9家，主力净增仓13家，暂未发现中长期投资价值。
截止2025-06-30，共69家主力机构（一般法人6家，基金63家），持仓量总计9803.77万股，占流通A股17.42%
其中，基金持仓与2024-12-31相比：
增仓：9家 ，增持 149.68万股
减仓：18家 ，减持 53.38万股
新出现在主力名单中：29家 ，持有84.75万股
从主力名单中消失：16家 ，原持有70.74万股
其中，基金持仓与2024-12-31相比：
增仓：9家 ，增持 149.68万股
减仓：18家 ，减持 53.38万股
新出现在主力名单中：29家 ，持有84.75万股
从主力名单中消失：16家 ，原持有70.74万股
消息面诊股
诊断结果：5.9消息面打败了30%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东富龙：公司实现国际业务收入8.05亿元，占营业收
2025-12-16 - 东富龙：12月15日获融资买入658.59万元
2025-12-16 - 东富龙：12月12日获融资买入1312.27万元
2025-12-15 - 东富龙：12月10日获融资买入1428.38万元
2025-12-11 - 东富龙：12月8日获融资买入908.08万元
2025-12-09 - 券商观点|医药生物行业周报：“医保&商保双目录”正
2025-12-08 - 东富龙：12月5日获融资买入792.15万元
2025-12-08 - 东富龙解锁布地奈德肠溶胶囊生产新范式
2025-12-05 - 【东东工艺指南】HPV疫苗生产纯化解决方案
2025-12-05 - 东富龙：12月4日获融资买入800.21万元
2025-12-05
消息列表
| 一般消息 | 募资投向 | 2025-09-19 | |
| 一般消息 | 高管变动 | 因《公司章程》等内部制度调整 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 利好 | 分红转增 | 10派0.3元(含税) | 2025-08-28 |
| 一般消息 | 高管变动 | 增强公司可持续发展能力 | 2025-08-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派0.76元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-15 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了57%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2025.12.16","price":"-1.51","value":null},{"date":"2025.12.15","price":"-1.10","value":null},{"date":"2025.12.12","price":"0.84","value":null},{"date":"2025.12.11","price":"-1.27","value":null},{"date":"2025.12.10","price":"0.29","value":null},{"date":"2025.12.09","price":"-0.39","value":null},{"date":"2025.12.08","price":"1.39","value":null},{"date":"2025.12.05","price":"1.08","value":null},{"date":"2025.12.04","price":"0.40","value":null},{"date":"2025.12.03","price":"-0.78","value":null},{"date":"2025.12.02","price":"-0.68","value":null},{"date":"2025.12.01","price":"1.25","value":null},{"date":"2025.11.28","price":"0.85","value":null},{"date":"2025.11.27","price":"-0.25","value":null},{"date":"2025.11.26","price":"1.02","value":null},{"date":"2025.11.25","price":"1.53","value":null},{"date":"2025.11.24","price":"0.37","value":null},{"date":"2025.11.21","price":"-3.41","value":null},{"date":"2025.11.20","price":"-0.76","value":null},{"date":"2025.11.19","price":"-0.00","value":null},{"date":"2025.11.18","price":"-0.92","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康众医疗 | 37.58% | 16.89% | 6.3分 |
| 2 | 英科医疗 | 14.47% | 2.32% | 5.5分 |
| 3 | 硕世生物 | 11.43% | 0.30% | 5.3分 |
| 4 | 五洲医疗 | 10.97% | 11.11% | 5.4分 |
| 5 | 浩欧博 | 9.27% | -0.81% | 5.1分 |
| 6 | 可孚医疗 | 5.87% | 2.38% | 6.4分 |
| 8 | 国发股份 | 5.49% | -6.53% | 4.6分 |
| 10 | 鱼跃医疗 | 1.85% | 0.51% | 5.9分 |
| 12 | 迈普医学 | 0.48% | 3.68% | 4.7分 |
| 14 | 热景生物 | 0.22% | -5.70% | 5.0分 |
| 16 | 威高血净 | 0.02% | 0.81% | 6.0分 |
| 18 | 福瑞股份 | -1.06% | -1.20% | 5.5分 |
| 20 | 九强生物 | -1.80% | -3.11% | 4.3分 |
| 22 | 正海生物 | -2.36% | -3.79% | 4.1分 |
| 24 | 麦克奥迪 | -2.97% | -3.51% | 5.2分 |
| 26 | 山东药玻 | -3.42% | 0.94% | 5.2分 |
| 28 | 蓝帆医疗 | -3.80% | 3.15% | 3.9分 |
| 30 | 安杰思 | -4.25% | -1.09% | 4.9分 |
| 32 | 采纳股份 | -4.41% | 1.23% | 4.2分 |
| 34 | 健帆生物 | -4.63% | -2.25% | 4.3分 |
| 36 | 麦澜德 | -4.99% | -3.91% | 5.1分 |
| 38 | 联影医疗 | -5.26% | -1.39% | 4.8分 |
| 40 | 维力医疗 | -5.59% | -2.95% | 5.3分 |
| 42 | 迈瑞医疗 | -5.76% | -1.96% | 5.0分 |
| 44 | 奕瑞科技 | -5.90% | -2.56% | 4.7分 |
| 46 | 基蛋生物 | -6.17% | -3.24% | 5.0分 |
| 48 | - | -6.21% | 5.86% | 分 |
| 50 | 中源协和 | -6.31% | -5.10% | 4.6分 |
| 52 | 伟思医疗 | -6.46% | -3.37% | 5.0分 |
| 54 | 普门科技 | -6.58% | -3.04% | 3.9分 |
| 56 | 心脉医疗 | -6.87% | -0.78% | 4.8分 |
| 58 | 康拓医疗 | -7.05% | -3.28% | 5.5分 |
| 60 | 赛科希德 | -7.22% | -3.25% | 4.1分 |
| 62 | - | -7.61% | 2.84% | 分 |
| 64 | - | -7.75% | 7.30% | 分 |
| 66 | 康德莱 | -8.10% | -3.34% | 4.7分 |
| 68 | 东星医疗 | -8.32% | -4.36% | 3.1分 |
| 70 | 奥泰生物 | -8.36% | -1.68% | 4.4分 |
| 72 | 开立医疗 | -8.43% | -0.82% | 4.4分 |
| 74 | 迪瑞医疗 | -8.52% | -3.48% | 3.7分 |
| 76 | 天臣医疗 | -8.86% | -5.42% | 5.4分 |
| 78 | 西山科技 | -9.20% | -2.92% | 3.9分 |
| 80 | - | -9.53% | -0.59% | 分 |
| 82 | ST凯利 | -9.57% | -2.66% | 4.5分 |
| 84 | 美康生物 | -9.79% | -4.31% | 3.2分 |
| 86 | 安旭生物 | -10.12% | -3.65% | 4.5分 |
| 88 | 亚辉龙 | -10.19% | -1.68% | 4.4分 |
| 90 | 明德生物 | -10.30% | -2.82% | 3.4分 |
| 92 | 黄山胶囊 | -10.63% | -7.20% | 4.6分 |
| 94 | 戴维医疗 | -10.91% | -2.57% | 4.2分 |
| 96 | 凯普生物 | -11.27% | -5.40% | 3.7分 |
| 98 | 海利生物 | -11.33% | -11.84% | 4.1分 |
| 100 | 尚荣医疗 | -11.58% | -6.51% | 4.4分 |
| 102 | 山外山 | -11.72% | -0.41% | 4.7分 |
| 104 | 阳普医疗 | -11.79% | -6.20% | 4.4分 |
| 106 | 之江生物 | -12.15% | -3.69% | 3.8分 |
| 108 | 康泰医学 | -12.28% | -3.68% | 3.4分 |
| 110 | 东方生物 | -12.31% | -2.16% | 3.7分 |
| 112 | 科美诊断 | -12.42% | -5.47% | 3.7分 |
| 114 | 仁度生物 | -13.11% | -5.86% | 4.7分 |
| 116 | 科华生物 | -13.33% | -6.56% | 3.7分 |
| 118 | 天益医疗 | -13.54% | -3.47% | 4.1分 |
| 120 | 爱威科技 | -14.27% | -5.50% | 5.1分 |
| 122 | 东富龙 | -14.64% | -2.72% | 4.5分 |
| 124 | 睿昂基因 | -15.04% | -7.00% | 4.4分 |
| 126 | 万泰生物 | -15.80% | -3.76% | 4.5分 |
| 128 | 港通医疗 | -16.32% | -8.10% | 3.8分 |
| 130 | 振德医疗 | -16.86% | -12.13% | 5.3分 |
| 132 | 安必平 | -18.44% | -6.25% | 3.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 85/246 ， 107/246。
[{"date":"2025-09-30","value":"1.68","vol":"2.92"},{"date":"2025-06-30","value":"0.59","vol":"2.31"},{"date":"2025-03-31","value":"0.26","vol":"1.15"},{"date":"2024-12-31","value":"2.47","vol":"0.62"},{"date":"2024-09-30","value":"1.94","vol":"4.68"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.68 | 0.59 | 0.26 | 2.47 | 1.94 |
| 行业(%) | 2.92 | 2.31 | 1.15 | 0.62 | 4.68 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"30.85","vol":"51.59"},{"date":"2025-06-30","value":"28.92","vol":"51.90"},{"date":"2025-03-31","value":"24.45","vol":"51.81"},{"date":"2024-12-31","value":"29.25","vol":"52.42"},{"date":"2024-09-30","value":"29.49","vol":"53.28"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
30.85 | 28.92 | 24.45 | 29.25 | 29.49 |
| 行业(%) | 51.59 | 51.90 | 51.81 | 52.42 | 53.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 37/246 ， 70/246。
[{"date":"2025-09-30","value":"6.14","vol":"-0.31"},{"date":"2025-06-30","value":"6.01","vol":"-1.69"},{"date":"2025-03-31","value":"2.58","vol":"-0.92"},{"date":"2024-12-31","value":"-11.19","vol":"0.59"},{"date":"2024-09-30","value":"-19.32","vol":"0.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.14 | 6.01 | 2.58 | -11.19 | -19.32 |
| 行业(%) | -0.31 | -1.69 | -0.92 | 0.59 | 0.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-13.86","vol":"-18.24"},{"date":"2025-06-30","value":"-59.71","vol":"-20.12"},{"date":"2025-03-31","value":"-68.87","vol":"-4.25"},{"date":"2024-12-31","value":"-67.66","vol":"-23.81"},{"date":"2024-09-30","value":"-73.82","vol":"-20.08"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-13.86 | -59.71 | -68.87 | -67.66 | -73.82 |
| 行业(%) | -18.24 | -20.12 | -4.25 | -23.81 | -20.08 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 50/246 ， 109/246。
[{"date":"2025-09-30","value":"0.28","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"},{"date":"2025-03-31","value":"0.09","vol":"0.08"},{"date":"2024-12-31","value":"0.39","vol":"0.36"},{"date":"2024-09-30","value":"0.27","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 0.18 | 0.09 | 0.39 | 0.27 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.77","vol":"1.67"},{"date":"2025-06-30","value":"0.52","vol":"1.12"},{"date":"2025-03-31","value":"0.26","vol":"0.55"},{"date":"2024-12-31","value":"1.03","vol":"2.32"},{"date":"2024-09-30","value":"0.69","vol":"1.65"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.77 | 0.52 | 0.26 | 1.03 | 0.69 |
| 行业(次) | 1.67 | 1.12 | 0.55 | 2.32 | 1.65 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"3.71","vol":"14.56"},{"date":"2025-06-30","value":"22.10","vol":"15.06"},{"date":"2025-03-31","value":"-0.79","vol":"4.01"},{"date":"2024-12-31","value":"29.74","vol":"29.50"},{"date":"2024-09-30","value":"19.73","vol":"15.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.71 | 22.10 | -0.79 | 29.74 | 19.73 |
| 行业 | 14.56 | 15.06 | 4.01 | 29.50 | 15.40 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.18","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.95","vol":"2.18"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.18 | - | 3.95 | - |
| 行业 | 0.00 | 1.57 | 0.00 | 2.18 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/246 ， 7/246。
[{"date":"2025-09-30","value":"2.01","vol":"5.66"},{"date":"2025-06-30","value":"2.01","vol":"5.47"},{"date":"2025-03-31","value":"2.07","vol":"5.89"},{"date":"2024-12-31","value":"1.99","vol":"5.32"},{"date":"2024-09-30","value":"2.03","vol":"5.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.01 | 2.01 | 2.07 | 1.99 | 2.03 |
| 行业 | 5.66 | 5.47 | 5.89 | 5.32 | 5.88 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.15","vol":"4.53"},{"date":"2025-06-30","value":"1.09","vol":"4.37"},{"date":"2025-03-31","value":"1.11","vol":"4.77"},{"date":"2024-12-31","value":"1.05","vol":"4.30"},{"date":"2024-09-30","value":"1.07","vol":"4.74"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.15 | 1.09 | 1.11 | 1.05 | 1.07 |
| 行业 | 4.53 | 4.37 | 4.77 | 4.30 | 4.74 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 10/246 ， 14/246。
[{"date":"2025-09-30","value":"39.19","vol":"22.09"},{"date":"2025-06-30","value":"39.36","vol":"22.06"},{"date":"2025-03-31","value":"38.09","vol":"21.24"},{"date":"2024-12-31","value":"38.43","vol":"21.98"},{"date":"2024-09-30","value":"38.44","vol":"20.76"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.19 | 39.36 | 38.09 | 38.43 | 38.44 |
| 行业(%) | 22.09 | 22.06 | 21.24 | 21.98 | 20.76 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.66","vol":"0.72"},{"date":"2025-06-30","value":"0.67","vol":"0.58"},{"date":"2025-03-31","value":"0.63","vol":"0.57"},{"date":"2024-12-31","value":"0.64","vol":"0.55"},{"date":"2024-09-30","value":"0.64","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.66 | 0.67 | 0.63 | 0.64 | 0.64 |
| 行业(%) | 0.72 | 0.58 | 0.57 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"8.28","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.18","blueLineValue":"0.15","type":"YC"}]